HomeTARA • NASDAQ
add
Protara Therapeutics Inc
Previous close
$2.98
Day range
$2.87 - $3.34
Year range
$1.04 - $5.24
Market cap
61.77M USD
Avg Volume
522.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 11.85M | 21.77% |
Net income | -11.10M | -22.66% |
Net profit margin | — | — |
Earnings per share | -0.97 | -21.25% |
EBITDA | -11.77M | -21.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 55.22M | -36.24% |
Total assets | 68.13M | -35.97% |
Total liabilities | 9.73M | -16.40% |
Total equity | 58.41M | — |
Shares outstanding | 20.59M | — |
Price to book | 0.58 | — |
Return on assets | -40.29% | — |
Return on capital | -43.12% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -11.10M | -22.66% |
Cash from operations | -10.38M | 19.47% |
Cash from investing | 23.10M | 134.28% |
Cash from financing | -76.00K | -18.75% |
Net change in cash | 12.64M | 508.96% |
Free cash flow | -7.55M | 24.56% |
About
Founded
2006
Website
Employees
27